
View Sessions
- Session I (Friday AM)
- Session II (Friday AM)
- Session III (Friday PM)
- Session IV (Saturday AM)
- Session V (Saturday AM)
- Session VI (Saturday PM)
- Session VII (Sunday AM)
- Session VIII (Sunday AM)
Friday, February 7th, 2020
7:15 AM- 7:45 AM
Registration, Breakfast & Exhibits
7:45 AM- 8:00 AM
Opening Remarks
Parta Hatamizadeh, MD, MPH | University of Florida | Course Director
Session I: Pulmonary Hypertension, The Heart and The Kidney
8:00 AM- 9:00 AM
Pulmonary Hypertension: The 2020 Overview
Mardi Gomberg-Maitland, MD, MSc | George Washington University
9:00 AM- 9:30 AM
Pulmonary Hypertension in Chronic Kidney Disease
Mark Sarnak, MD, MS | Tufts University
9:40 AM- 10:00 AM
Panel Discussion
10:00 AM- 10:30 AM
Break & Exhibits
Session II: Systemic Hypertension Review and Update
10:30 AM- 11:30 AM
Latest Advances in Hypertension
George Bakris, MD | University of Chicago
11:30 AM – 12:30 PM
Specific Aspects and Subtleties of Hypertension and Blood Pressure Management in Patients with Cardiovascular Diseases
Suzanne Oparil, MD | University of Alabama at Birmingham (UAB)
12:30 PM- 1:30 PM
Lunch & Exhibits
Session III: Dyslipidemia, Cardiovascular System and Kidney
1:30 PM- 2:30 PM
Contemporary Approach to Lipid Management in Cardiovascular Patients
Karol Watson, MD, PhD | UCLA David Geffen School of Medicine
2:30PM – 3:10 PM
Evidence Based Approach to Lipids and Dyslipidemia in Patients with Chronic Kidney Disease
Mark Sarnak, MD, MS | Tufts University
3:10PM – 3:30 PM
Panel Discussion
Saturday, February 8, 2020
7:15 AM- 8:00 AM
Registration, Breakfast & Exhibits
Session IV: Diabetes Mellitus: Kidney and Cardiovascular System
8:00 AM- 8:50 AM
The 2020 Outlook of Diabetes and Diabetic Nephropathy from the Nephrology Standpoint
George Bakris, MD | University of Chicago
8:50 AM- 9:40 AM
State of the Art Approach to Diabetes and Glycemic Control from the Cardiology Standpoint
Karol Watson, MD, PhD | UCLA David Geffen School of Medicine
9:40 AM- 10:00 AM
Evidence Based Approach to Glycemic Control with Newly Emerged Therapies
10:00 AM- 10:30 AM
Break & Exhibits
Session V: Uric Acid and Hyperuricemia: Kidney and Cardiovascular System
10:30 AM- 11:20 AM
Overview and Update on Uric Acid and Hyperuricemia
N. Lawrence Edwards, MD | University of Florida
11:20 AM – 12:10 PM
Hyperuricemia in Kidney Diseases and Cardiovascular Diseases
Richard Johnson, MD | University of Colorado
12:10 pM – 12:30 PM
Panel Discussion: Asymptomatic Hyperuricemia: To Treat or not to Treat?
12:30 PM- 1:30 PM
Lunch & Exhibits
Session VI: Amyloidosis, Deposition Diseases, and Other Connections Between Kidney and Cardiovascular Diseases
1:30 PM- 2:10 PM
Cardiac Amyloidosis: What is New?
Rodney H. Falk, MD | Harvard University
2:10 PM- 2:50 PM
Renal Amyloidosis and Deposition Diseases
Mark Segal, MD, PhD | University of Florida
2:50 PM- 3:30 PM
Clinical Importance of The Connection Between Renal Glomerular Diseases and Cardiovascular Diseases
Parta Hatamizadeh, MD, MPH | University of Florida
Sunday, February 9th, 2020
7:15 AM- 8:00 AM
Registration, Breakfast & Exhibits
Session VII: Inflammation, Immune System, The Heart and The Kidney
8:00 AM- 9:00 AM
Updates on Myocarditis and Cardiac Inflammation: What Does a Clinician Need to Know?
Leslie T. Cooper, JR, MD | Mayo Clinic
9:00 AM- 10:00 AM
Autoimmunity, Inflammation and Kidney Diseases in Clinical Practice
Laura Mariani, MD, MS | University of Michigan
10:00 AM- 10:30 AM
Break & Exhibits
Session VIII: Abstract presentation and General Question and Answer
10:30AM – 10:50AM
Portal vein flow guided decongestion in cardio-renal syndrome: A POCUS Series
Eduardo Argaiz, MD | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirám
10:50AM – 11:10AM
Parity and Cardiovascular Disease Risk in Women with Chronic Kidney Disease
Sandra Dumanski, MD | University of Calgary
11:10AM – 11:30AM
Outcome in hospitalized patients treated with PRN anti-HTN medications: A single center experience
Gajapathiraju Chamarthi, MD | University of Florida
11:30AM – 11:50AM
Open-Source Software for Measuring Vascular Compliance from DICOM Ultrasound Data
Timothy Morgan, PhD | University of Michigan
11:50AM – 12:30PM
Question and Answer
Leslie Cooper, MD; Mark Segal, MD, PhD, Laura Mariani, MD, MS; Parta Hatamizadeh, MD, MPH
12:30 PM
Closing Remarks
Parta Hatamizadeh, MD, MPH | University of Florida | Course Director